Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
antidepressant |
| gptkbp:activeIngredient |
tianeptine
|
| gptkbp:alternativeName |
gptkb:Coaxil
gptkb:Tatinol tianeptine sodium |
| gptkbp:ATCCode |
N06AX14
|
| gptkbp:chemicalClass |
tricyclic compound
|
| gptkbp:compatibleWith |
gptkb:United_States
|
| gptkbp:developedBy |
gptkb:Servier_Laboratories
|
| https://www.w3.org/2000/01/rdf-schema#label |
Stablon
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketedAs |
1980s
|
| gptkbp:marketedIn |
gptkb:Asia
gptkb:France gptkb:Russia |
| gptkbp:mechanismOfAction |
atypical antidepressant
serotonin reuptake enhancer |
| gptkbp:riskFactor |
dependence
abuse potential |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
abdominal pain constipation drowsiness |
| gptkbp:usedFor |
gptkb:depression
gptkb:major_depressive_disorder |
| gptkbp:bfsParent |
gptkb:Tianeptine
|
| gptkbp:bfsLayer |
7
|